Pfizer Profit Tops Analyst Estimates on Pain Drug, Vaccine Sales – BusinessWeek

Category: Nutrition | November 1, 2011 | Comments: 0 Comments

Pfizer is considering a sale or spinoff of its nutrition and animal health units to focus on bringing new drugs to market and prepare for generic competition to Lipitor, the world’s best-selling drug with $ 10.7 billion in annual sales.

“We hope the Nordic diet can be a legitimate alternative to the Mediterranean diet,” Thomas Larsen, an associate professor of nutrition and the study’s head, said in an interview. “The ingredients are the same as Noma, the fact that it

Pfizer is considering a sale or spinoff of its nutrition and animal health units to focus on bringing new drugs to market and prepare for generic competition to Lipitor, the world’s best-selling drug with $ 10.7 billion in annual sales.

  • pfizer nutrition sale
  • pfizer nutrition spin off
  • latest on pfizer nutrition sale
  • latest news on pfizer nutrition spin off
  • Pfizer animal health - current news

Leave a Reply

You must be logged in to post a comment.